EAN NewsEAN NewsResearchTop Articles
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus
Despite its large use, recommendations for the use of brain F-18 FDG-PET in clinical practice were still lacking.
The European Academy of Neurology (EAN) and the European Association of Nuclear Medicine (EANM) promoted a concerted action with 7 specialists from the two Societies and a group of facilitators in order to make the point on this issue. Extensive literature review and analysis of available data led, together with expert opinion (Delphi consensus), to deliver these recommendations that cover practically all the main brain neurodegenerative conditions causing cognitive impairment.










Prof. F. Fazekas, President of the EAN and Prof. W. Struhal President of EFAS are pleased to announce that:
EAN has joined with EFAS to promote Autonomic Nervous System (ANS) disorders in Europe and advance optimal care and management for…
GAMIAN-Europe, a patient-driven pan-European organization, represents the interests
of persons affected by mental illness and advocates their right
www.gamian.eu
GAMIAN Europe: European Parliament Interest Group on Mental Health, Well-being and Brain Disorders
European Parliament, Brussels, Belgium, 16 May 2018…
Clean air for brain health
Mohammad Wasay MD, FRCP, FAAN (Aga Khan University, Karachi, Pakistan)
by Anna Sauerbier
Digital medicine and treatment development for brain disorders
AZ, Lilly pull plug on Alzheimer’s disease trials
France builds first Alzheimer’s ‘village’ in pioneering experiment
Horizon Europe budget not big…